Kronox Lab Sciences Intrinsic Value
Kronox Lab Sciences (KRONOX) median intrinsic value is ₹58.38 from 9 valuation models (range ₹27–₹114), vs current price ₹134.25 — -56.5% downside (Trading Above Calculated Value), margin of safety -100.0%. For current market price and key ratios, visit Kronox Lab Sciences screener.
KRONOX Valuation Methods Summary — DCF, Graham Number & P/E
Kronox Lab Sciences intrinsic value across 9 models vs current price ₹134.25 — upside/downside and value range per method. Also explore Kronox Lab Sciences share price performance to track price trends across different timeframes.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹84.00 | ₹67.20 - ₹100.80 | -37.4% | EPS: ₹7.00, Sector P/E: 12x |
| Book Value Method | asset | ₹26.85 | ₹24.17 - ₹29.54 | -80.0% | Book Value/Share: ₹24.32, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹40.27 | ₹36.24 - ₹44.30 | -70.0% | Revenue/Share: ₹28.38, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹58.38 | ₹52.54 - ₹64.22 | -56.5% | EBITDA: ₹36.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹113.81 | ₹91.05 - ₹136.57 | -15.2% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹106.43 | ₹95.79 - ₹117.07 | -20.7% | EPS Growth: 19.0%, Fair P/E: 15.2x |
| Growth Adjusted P/E | growth | ₹57.70 | ₹51.93 - ₹63.47 | -57.0% | Revenue Growth: 6.1%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹112.43 | ₹101.19 - ₹123.67 | -16.3% | ROE: 28.9%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹48.65 | ₹43.78 - ₹53.52 | -63.8% | EPS: ₹7.00, BVPS: ₹24.32 |
KRONOX Intrinsic Value vs Market Price — All Valuation Models
Kronox Lab Sciences fair value range ₹27–₹114 vs current market price ₹134.25 across 9 valuation models. Browse KRONOX balance sheet details for revenue, profit, balance sheet and cash flow data.
KRONOX Intrinsic Value Analysis — Undervalued or Overvalued?
Kronox Lab Sciences median intrinsic value ₹58.38, current price ₹134.25 — Trading Above Calculated Value by 56.5%, margin of safety -100.0%.
What is the intrinsic value of KRONOX?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Kronox Lab Sciences (KRONOX) is ₹58.38 (median value). With the current market price of ₹134.25, this represents a -56.5% variance from our estimated fair value.
The valuation range spans from ₹26.85 to ₹113.81, indicating ₹26.85 - ₹113.81.
Is KRONOX undervalued or overvalued?
Based on our multi-method analysis, Kronox Lab Sciences (KRONOX) appears to be trading above calculated value by approximately 56.5%.
KRONOX Financial Health — Key Ratios vs Industry Benchmarks
Kronox Lab Sciences financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Return on Equity | 28.9% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 32.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.06x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
KRONOX Cash Flow Quality — Operating & Free Cash Flow
Kronox Lab Sciences operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹31 Cr | ₹17 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹17 Cr | ₹9 Cr | Positive Free Cash Flow | 7/10 |
| March 2023 | ₹20 Cr | ₹17 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹9 Cr | ₹5 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹11 Cr | ₹10 Cr | Positive Free Cash Flow | 8/10 |